Who
Adam Scott Levy
CFO and Secretary
Company insider
Files Form 4 as: CFO and Secretary, Mineralys Therapeutics; Chief Business Officer, Brickell Biotech; Chief Business Officer, Viridian Therapeutics.
In numbers
- Trades disclosed
- 47
- Buys
- 3
- Sells
- 12
- Bought
- $152K
- Sold
- $9.5M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 16 Feb 2017
- Last trade
- 19 Feb 2026
- Last filed
- 20 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Feb 2026filed 20 Feb 2026 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Code A | —39,900 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | MLYS Mineralys Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,300 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | MLYS Mineralys Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,300 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Code A | —39,900 at $0.00 | filing |
| 12 Jan 2026filed 13 Jan 2026 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Sold | $346K10,758 at $32.14 | filing |
| 12 Jan 2026filed 13 Jan 2026 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Sold | $346K10,758 at $32.14 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,547 at $0.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —34,414 at $0.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —44,079 at $0.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,613 at $0.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Code M | $210K20,547 at $10.20 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Code M | $551K34,414 at $16.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Code M | $628K44,079 at $14.25 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Code M | $102K6,613 at $15.44 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Sold | $43K1,015 at $42.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Sold | $473K11,295 at $41.87 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Sold | $67K1,561 at $42.68 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Sold | $539K12,952 at $41.65 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Sold | $359K8,485 at $42.34 | filing |
| 11 Nov 2025filed 13 Nov 2025 | MLYS Mineralys TherapeuticsBiotechnology | SEC FORM 4 Sold | $180K4,142 at $43.50 | filing |
News
Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel CoatsMLYS · manilatimes.net · 19 Oct 2026
0 headlines in the last 90 days name Adam Scott Levy; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.